High performing – unique – clinically proven
Visco booster with dual effect based on hyaluronic acid combined with niacinamide.
1 Hummer, C.D., Angst, F., Ngai, W. et al. High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis. BMC Musculoskelet Disord 21, 702 (2020). https://doi.org/10.1186/s12891-020-03729-w
2 Ogata S, Takeuchi M, Teradaira S, Yamamoto N, Iwata K, Okumura K, Taguchi H. Radical scavenging activities of niacin related compounds. Biosci Biotechnol Biochem. 2002 Mar;66(3):641-5. doi: 10.1271/bbb.66.641. PMID: 12005062
3 Jonas WB, Rapoza CP, Blair WF. The effect of niacinamide on osteoarthritis: a pilot study. Inflamm Res. 1996 Jul; 45(7):330-4. doi: 10.1007/BF02252945. PMID: 8841834
4 Atlantic Bone Screen, assigned by ALBOMED GmbH. In-vitro evaluation of the anti-hypertrophic effect of 1 product on rat chondrocytes. 2019
INNORYOS®
The first visco booster for osteoarthritis patients with dual effect of hyaluronic acid and niacinamide (antioxidative effect, limits inflammation) shows best overall functional behavior for dynamic activities:
Altogether, INNORYOS® maximizes the osteoarthritis treatment outcomes.
Below you will find the specification of the INNORYOS® product line, including the color coding that helps to easily distinguish between the different concentrations.
* mean value after steam sterilization
Headoffice
ALBOMED GmbH
Hildebrandstr. 11
90592 Schwarzenbruck | Germany
info@albomed.eu
+49 (0) 9183 95 69 82-0
Facility UNNA I | Logistic center
Otto-Brenner-Str. 7
59425 Unna | Germany
Facility UNNA II | Production
Isaac-Newton-Str. 7
59423 Unna | Germany